355
Views
5
CrossRef citations to date
0
Altmetric
Reviews

Neurotensin, a Novel Messenger to Cross-Link Inflammation and Tumor Invasion via Epithelial-Mesenchymal Transition Pathway

, , , , , , & show all
Pages 340-350 | Accepted 20 Jul 2014, Published online: 12 Sep 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ting-Ting Yu, Tao Zhang, Xi Lu & Ruo-Zheng Wang. (2018) B7-H3 promotes metastasis, proliferation, and epithelial-mesenchymal transition in lung adenocarcinoma. OncoTargets and Therapy 11, pages 4693-4700.
Read now

Articles from other publishers (4)

José Arimatéa de Oliveira Nery Neto, Victor Yuji Yariwake, Niels Olsen Saraiva Câmara & Vinicius Andrade-Oliveira. (2023) Enteroendocrine cells and gut hormones as potential targets in the crossroad of the gut-kidney axis communication. Frontiers in Pharmacology 14.
Crossref
Ilaria Barchetta, Marco Giorgio Baroni, Olle Melander & Maria Gisella Cavallo. (2022) New Insights in the Control of Fat Homeostasis: The Role of Neurotensin. International Journal of Molecular Sciences 23:4, pages 2209.
Crossref
Niki Christou, Sabrina Blondy, Valentin David, Mireille Verdier, Fabrice Lalloué, Marie-Odile Jauberteau, Muriel Mathonnet & Aurélie Perraud. (2020) Neurotensin pathway in digestive cancers and clinical applications: an overview. Cell Death & Disease 11:12.
Crossref
Yumei Duan, Zhi Li, Shiyue Cheng, Yan Chen, Lu Zhang, Jiang He, Qiong Liao, Lifang Yang, Zhicheng Gong & Lun-Quan Sun. (2015) Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway. Cancer Letters 361:1, pages 67-74.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.